Results 161 to 170 of about 29,370 (221)
Expanding clones, expanding aneurysms through macrophage-to-osteoclast differentiation. [PDF]
Regan JA, Shah SH.
europepmc +1 more source
Radiographic Evolution of Contralateral Asymptomatic Incomplete Atypical Femoral Fractures in Autoimmune Disease Patients. [PDF]
Nishino T +7 more
europepmc +1 more source
Beyond bone effects: the role of denosumab in muscle Health - A systematic review. [PDF]
Ceolin C +5 more
europepmc +1 more source
Harmonized quantitative bone SPECT/CT parameters for risk assessment of medication-related osteonecrosis of the jaw: multicenter study. [PDF]
Kitajima K +10 more
europepmc +1 more source
Molecular Mechanisms and Therapeutic Targets for Pain Following Osteoporotic Vertebral Fractures. [PDF]
Zhou H, Wu K.
europepmc +1 more source
Does alendronate enhance survival rates in osteoporosis patients? A meta-analysis of randomized controlled trials. [PDF]
Sun R +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Treatments in Endocrinology, 2005
Alendronate/colecalciferol 70 mg/2800 IU, a once-weekly tablet containing the bisphosphonate alendronate and colecalciferol (the precursor of the biologically active form of vitamin D), has been approved for the treatment of osteoporosis in women and for increasing bone mass in men with osteoporosis.
Neil A, Reynolds, Monique P, Curran
openaire +2 more sources
Alendronate/colecalciferol 70 mg/2800 IU, a once-weekly tablet containing the bisphosphonate alendronate and colecalciferol (the precursor of the biologically active form of vitamin D), has been approved for the treatment of osteoporosis in women and for increasing bone mass in men with osteoporosis.
Neil A, Reynolds, Monique P, Curran
openaire +2 more sources

